about
Vaxign: the first web-based vaccine design program for reverse vaccinology and applications for vaccine developmentVirulence and Fitness Determinants of Uropathogenic Escherichia coliPreferential use of central metabolism in vivo reveals a nutritional basis for polymicrobial infectionSslE elicits functional antibodies that impair in vitro mucinase activity and in vivo colonization by both intestinal and extraintestinal Escherichia coli strainsFdeC, a Novel Broadly Conserved Escherichia coli Adhesin Eliciting Protection against Urinary Tract InfectionsHelicobacter pylori HP1512 is a nickel-responsive NikR-regulated outer membrane proteinAutotransporter genes pic and tsh are associated with Escherichia coli strains that cause acute pyelonephritis and are expressed during urinary tract infection.Multiple genes repress motility in uropathogenic Escherichia coli constitutively expressing type 1 fimbriae.Visualization of Proteus mirabilis within the matrix of urease-induced bladder stones during experimental urinary tract infectionA novel approach for transcription factor analysis using SELEX with high-throughput sequencing (TFAST).Quantitative profile of the uropathogenic Escherichia coli outer membrane proteome during growth in human urine.Fitness of Escherichia coli during urinary tract infection requires gluconeogenesis and the TCA cycle.Mucosal immunization with iron receptor antigens protects against urinary tract infection.Waging war against uropathogenic Escherichia coli: winning back the urinary tractThe innate immune response to uropathogenic Escherichia coli involves IL-17A in a murine model of urinary tract infectionCapsule Production and Glucose Metabolism Dictate Fitness during Serratia marcescens Bacteremia.Escherichia coli global gene expression in urine from women with urinary tract infection.The IrgA homologue adhesin Iha is an Escherichia coli virulence factor in murine urinary tract infection.Identification of in vivo-induced antigens including an RTX family exoprotein required for uropathogenic Escherichia coli virulence.Transcriptome of swarming Proteus mirabilisZinc uptake contributes to motility and provides a competitive advantage to Proteus mirabilis during experimental urinary tract infectionTnseqDiff: identification of conditionally essential genes in transposon sequencing studies.Role of motility in the colonization of uropathogenic Escherichia coli in the urinary tract.Coordinate expression of fimbriae in uropathogenic Escherichia coliIn vivo behavior of a Helicobacter pylori SS1 nixA mutant with reduced urease activityUrease of enterohemorrhagic Escherichia coli: evidence for regulation by fur and a trans-acting factor.Assessment of virulence of uropathogenic Escherichia coli type 1 fimbrial mutants in which the invertible element is phase-locked on or offSat, the secreted autotransporter toxin of uropathogenic Escherichia coli, is a vacuolating cytotoxin for bladder and kidney epithelial cells.Proteobactin and a yersiniabactin-related siderophore mediate iron acquisition in Proteus mirabilis.Adhesion, invasion, and agglutination mediated by two trimeric autotransporters in the human uropathogen Proteus mirabilisA conserved PapB family member, TosR, regulates expression of the uropathogenic Escherichia coli RTX nonfimbrial adhesin TosA while conserved LuxR family members TosE and TosF suppress motility.Role of phase variation of type 1 fimbriae in a uropathogenic Escherichia coli cystitis isolate during urinary tract infection.Dissemination and systemic colonization of uropathogenic Escherichia coli in a murine model of bacteremia.Mannose-resistant Proteus-like fimbriae are produced by most Proteus mirabilis strains infecting the urinary tract, dictate the in vivo localization of bacteria, and contribute to biofilm formationAnaerobic respiration using a complete oxidative TCA cycle drives multicellular swarming in Proteus mirabilis.Arginine promotes Proteus mirabilis motility and fitness by contributing to conservation of the proton gradient and proton motive force.UreR, the transcriptional activator of the Proteus mirabilis urease gene cluster, is required for urease activity and virulence in experimental urinary tract infections.Preventing urinary tract infection: progress toward an effective Escherichia coli vaccine.Lipocalin 2 imparts selective pressure on bacterial growth in the bladder and is elevated in women with urinary tract infectionNutritional requirements and antibiotic resistance patterns of Helicobacter species in chemically defined media.
P50
Q21328677-4E66EB11-89F8-416B-84A7-3A72C4B9B45AQ26782598-AAF4450B-70BE-4DCD-AD3E-CDB3EABE7193Q27321660-A441A1CE-20FC-4299-8F6D-358E1061BF9EQ27325713-535F707D-3A16-4911-909E-567A027EF8E1Q27678478-F231AF2A-C5E1-4C2A-9E5C-44FF6D23B195Q29346541-27E0E2B8-365B-4293-A83C-689F66F9CC79Q30164331-718BBD59-F977-495E-A8D0-3E0517E14F88Q30482051-52EDBB7F-DC81-4F9C-8723-B8647B0DFAC1Q31032712-B5C617D3-1A44-4920-A9CD-B0F3DCD324B3Q31089638-6BB1C9BE-59FF-4C8A-AC0D-A5D1E9C40FE4Q33285142-771421AE-4EBE-43A9-B158-4C2A53B3D684Q33455526-1446DE6D-AAF4-4694-A325-AA8721D42AC0Q33508792-1D91981B-7616-4FA7-9D88-301376E3BC05Q33613902-C5E07A01-4EDB-4779-ABD3-BEA4389C41E0Q33652449-D8900A3B-2D95-4B2E-9FB5-179E9055F84FQ33721356-6037E057-0130-4471-8370-1A5D09608E04Q33750030-6A636E33-CBDE-48EE-BC97-8F47F43AE4CFQ33794411-41254BD6-096D-4F66-BA13-4B992137A556Q33851098-D0337D9C-1341-4609-ADA6-264B2BACEBF7Q33877234-11065A8E-D8FA-44DE-B74F-4A4D23EC97FFQ33877269-0FDC8BD8-1EAF-4A6A-B3D6-2910E98B05D8Q33882446-F940EB72-DACE-47E8-B0B1-9FBBBFE21087Q34111747-52908E5B-C23F-48EF-AACE-C068D2AAFBCCQ34111922-AC217857-9B59-48B2-93F6-AE3E2FF41AA4Q34116643-3AEC2132-C6FF-49E1-B51F-FA697E8124A6Q34117156-14FC3FB3-7912-4305-898B-26E489A3747EQ34125257-576BA648-FBAA-47DA-8436-D83B30D566CBQ34128314-AF5A9531-9D93-41F5-838E-EDE9D7A7CB9EQ34183602-9F7618AD-6696-49C2-B085-08F7320B089BQ34290694-2D07D542-41A0-4119-8569-A471AA8BD7EBQ34298360-0BF23D73-A1B3-4778-B187-530B2BBEA48DQ34334332-2C1A1F44-6B6E-475E-B598-8888779EE79FQ34356627-29D13EC9-A8A0-4A3E-A24E-3C22B36F4B93Q34370224-E9449248-24D4-4248-834B-3FC6A75C8A7FQ34461913-E39277AD-F8D6-4645-84C3-60CC47BB1C2FQ34523872-06130546-BCC1-423C-A769-969A3B9F33D9Q34582159-84D0E8CF-48CA-4DE3-B0B8-1450247831CAQ34641267-5ED81491-5021-4537-B67E-9B40C190FBF9Q34646648-EE14A5FF-338D-4A00-97DB-E800EB4E708AQ34680804-BB8F303D-023C-429C-B2CF-BB01B49264ED
P50
description
researcher
@en
wetenschapper
@nl
name
Harry L T Mobley
@ast
Harry L T Mobley
@en
Harry L T Mobley
@nl
type
label
Harry L T Mobley
@ast
Harry L T Mobley
@en
Harry L T Mobley
@nl
prefLabel
Harry L T Mobley
@ast
Harry L T Mobley
@en
Harry L T Mobley
@nl
P1006
P214
P1006
P106
P214
P31
P496
0000-0001-9195-7665
P735
P7859
lccn-n95802400